Artikel ; Online: Iperaldosteronismo primitivo: dalla diagnosi alla terapia nella pratica clinica.
Giornale italiano di cardiologia (2006)
2021 Band 22, Heft 4, Seite(n) 319–326
Abstract: Primary aldosteronism (PA) is the single most common cause of secondary hypertension and is associated with increased target organ injury. It can be can either surgically cured or treated with targeted pharmacotherapy. PA is frequently undiagnosed and ... ...
Titelübersetzung | Primary aldosteronism: from diagnosis to therapy in clinical practice. |
---|---|
Abstract | Primary aldosteronism (PA) is the single most common cause of secondary hypertension and is associated with increased target organ injury. It can be can either surgically cured or treated with targeted pharmacotherapy. PA is frequently undiagnosed and untreated, leading to aldosterone-specific cardiovascular morbidity and nephrotoxicity. Thus, clinicians should perform case detection testing for PA at least once in all patients with hypertension. The diagnostic work-up of PA is a sequence of three phases comprising screening tests, confirmatory tests and the differentiation of unilateral from bilateral forms. With appropriate surgical expertise, laparoscopic unilateral adrenalectomy is safe, efficient and curative in patients with unilateral adrenal disease. In patients who have bilateral aldosterone hypersecretion, the optimal management is a low sodium diet and lifelong treatment with a mineralocorticoid receptor antagonist administered at a dosage to maintain a high-normal serum potassium concentration without the aid of oral potassium supplements. In patients with PA, specific treatment provides prognostic benefit over optimal antihypertensive therapy and is therefore crucial to reduce mortality and morbidity in this subgroup of patients with hypertension. |
Mesh-Begriff(e) | Adrenalectomy ; Aldosterone ; Humans ; Hyperaldosteronism/surgery ; Hyperaldosteronism/therapy ; Hypertension/diagnosis ; Hypertension/drug therapy ; Hypertension/etiology ; Mineralocorticoid Receptor Antagonists/therapeutic use |
Chemische Substanzen | Mineralocorticoid Receptor Antagonists ; Aldosterone (4964P6T9RB) |
Sprache | Italienisch |
Erscheinungsdatum | 2021-03-30 |
Erscheinungsland | Italy |
Dokumenttyp | Journal Article |
ZDB-ID | 2272414-X |
ISSN | 1972-6481 ; 1827-6806 |
ISSN (online) | 1972-6481 |
ISSN | 1827-6806 |
DOI | 10.1714/3574.35578 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.A 6738: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.